How big is the Transthyretin Amyloidosis Treatment Market?

The Transthyretin Amyloidosis Treatment Market size is expected to reach USD 5.30 billion in 2024 and grow at a CAGR of 15.40% to reach USD 10.90 billion by 2029. Read More

What is the current Transthyretin Amyloidosis Treatment Market size?

In 2024, the Transthyretin Amyloidosis Treatment Market size is expected to reach USD 5.30 billion. Read More

Who are the key players in Transthyretin Amyloidosis Treatment Market?

Pfizer Inc., Ionis Pharmaceuticals, Alnylam Pharmaceuticals, Inc., BridgeBio Inc and Intellia Therapeutics, Inc. are the major companies operating in the Transthyretin Amyloidosis Treatment Market. Read More

Which is the fastest growing region in Transthyretin Amyloidosis Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Transthyretin Amyloidosis Treatment Market?

In 2024, the North America accounts for the largest market share in Transthyretin Amyloidosis Treatment Market. Read More

What years does this Transthyretin Amyloidosis Treatment Market cover, and what was the market size in 2023?

In 2023, the Transthyretin Amyloidosis Treatment Market size was estimated at USD 4.48 billion. The report covers the Transthyretin Amyloidosis Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Transthyretin Amyloidosis Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Transthyretin Amyloidosis Treatment Market Share

Statistics for the 2023 & 2024 Transthyretin Amyloidosis Treatment market share, created by Mordor Intelligence™ Industry Reports. Transthyretin Amyloidosis Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Transthyretin Amyloidosis Treatment Industry

The transthyretin amyloidosis treatment market is moderately consolidated in nature due to the presence of limited companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, including Pfizer Inc., Ionis Pharmaceuticals, Alnylam Pharmaceuticals Inc., Intellia Therapeutics Inc., and BridgeBio Inc.